Dennis Hom
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/05/2024
Profilo
Dennis Hom worked as an Executive Director of Corporate Development at Amgen, Inc. from 2011 to 2012.
He then worked as a Vice President of Finance and Corporate Development at Achaogen, Inc. from 2013 to 2014.
Currently, he is the CFO and Head of Corporate Development at Sagimet Biosciences, Inc. starting from 2017 and continuing until 2023.
Hom received his undergraduate degree from the Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/07/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Precedenti posizioni note di Dennis Hom
| Società | Posizione | Fine |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Direttore Finanziario/CFO | 01/08/2023 |
| ACHAOGEN | Direttore Finanziario/CFO | 31/03/2014 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Dennis Hom
